Trending
October 24, 2024

Avalon GloboCare Announces 1-for-15 Reverse Stock Split

October 23, 2024

DeepIntent Recognized as a 2024 Best Place to Work by Crain’s New York

October 23, 2024

Alphina Therapeutics Appoints Nick Galli as Chief Executive Officer

October 23, 2024

Interview with Adam Low, CEO of SENTA Partners

October 23, 2024

Modifi Biosciences Acquired by Merck

October 22, 2024

Nodenza Venture Partners Invests In Trellis Bioscience

October 21, 2024

Norton L. Travis Joins Rivkin Radler as Counsel

October 21, 2024

HSS Appoints Daphne A. Scott, MD, Chief of Primary Sports Medicine

October 17, 2024

Pip Care Raises $5M

October 16, 2024

ObvioHealth Appoints Richard Watkins as Chief Revenue Officer

October 16, 2024

Volastra Therapeutics Appoints Samuel Bakhoum, M.D., Ph.D., as Chief Scientific Officer

October 16, 2024

Healthcasts Names Max Baumer Chief Operating Officer & Chief Financial Officer

October 15, 2024

FlyteHealth Appoints Gabe Castaneda as Chief Revenue Officer and Names Cheryl Pegus as Executive Board Chair

October 15, 2024

AllazoHealth Appoints Joy Neely, Nagaraja Srivatsan, and Kenneth Ziegler to Advisory Board

October 15, 2024

First Fertility Appoints Mike Rzendzian, CPA, MBA, as Chief Financial Officer

October 15, 2024

Allyx Therapeutics Awarded $3.3 Million NIH Grant